3rd Scientific Congress of the Progressive MS Alliance: Making a difference through rehabilitation and Symptom Management (Part 2)

Taking the lessons learned from stroke research (part 1) and moving forward to develop new projects and programs is important for the advancement of research in rehabilitation and symptom management in progressive multiple sclerosis (MS). For this post, I’ll be highlighting areas that garnered interest at the Progressive MS Alliance meeting such as brain stimulation, robotics, exercise, cognition, and patient perspectives.congress 1

Continue reading

3rd Scientific Congress of the Progressive MS Alliance: Making a difference through rehabilitation and Symptom Management (Part 1)

pic 1

“The whole is greater than the sum of its parts,” quoted by Aristotle and reiterated by Dr. Anthony Feinstein, a neurologist at Sunnybrook Hospital in Toronto and co-chair of the 3rd Scientific Congress of the Progressive MS Alliance.

This quote speaks to the holistic culture of the meeting, which brought together global leaders in the field to assess the challenges of progressive multiple sclerosis (MS) research – with a particular focus on rehabilitation and symptom management. With over 220 participants from 16 countries, this was the largest Congress to date for the Alliance. Throughout the week, researchers and clinicians provided their insights on lessons that can be learned from other conditions such as stroke and spinal cord injury, and shared their research on symptom management and rehabilitation – including brain stimulation, robotics, patient perspectives, exercise and cognition, and how they could be applied specifically in MS. Continue reading

Incidence and Prevalence: What do they mean, how new numbers are identified and why they are important?

Incidence and prevalence are two terms that are frequently used in epidemiology but are often mixed up or used incorrectly. Epidemiology is a branch of research that studies the distribution and determinants of health and illness within populations. Data generated from epidemiological research informs public health and can help understand the history of a disease and determine who is at risk of developing a disease. Distinguishing these two terms is important when discussing the patterns, causes, and effects of MS in the population.

What do incidence and prevalence mean?

Continue reading

American Academy of Neurology: Multiple Sclerosis risk factors and susceptibility


artificial-intelligence-3382507__340During the annual American Academy of Neurology meeting, researchers shared their thoughts and presented recent discoveries on risk factors and susceptibility in multiple sclerosis (MS)—a hot topic in the field. Who develops this chronic illness and why are questions that are still puzzling the research community. In general, it’s agreed that a combination of genes and environmental factors likely play a role in the development of MS.

There is an expanding list of risk factors associated with MS including those that fall in the following categories: environmental, infectious and genetic. The studies reported in this blog will focus primarily on environmental risk factors.

Continue reading